CCNA2 and ovarian carcinoma: With respect to cell cycle regulation, cepharanthine enhances p21Waf1 expression in ovarian cancer and p53-mutant colorectal cancer cells while suppressing cyclin A and cyclin D levels, inducing G1 phase cell cycle arrest, and effectively inhibiting ovarian cancer cell proliferation [23,24].